tirzepatide heart failure trial Cardiovascular outcomes of semaglutide and for patients with type 2 diabetes in clinical practice Tirzepatide Helps in HFpEF Across

Kidney Stress Acute kidney injury has been reported, typically in patients who experienced severe vomiting or diarrhea that led to significant dehydration

Steady fat loss begins typically 13 lbs per week with lifestyle support

16 GLP-1RAs achieve sustained pharmacological effects by resisting degradation by DPP-4 in the body, consequently contributing to hyperglycemia and insulin resistance related to glucose metabolism, 17,18 lipid profile alterations, changes in fat composition, visceral fat accumulation, and obesity related to lipid metabolism, 1921 which constitute the systemic metabolic characteristics of interest in MASLD management

After week 4, I added collagen (for additional joint support) and omega-3s (for inflammation)

Changes in other medications dose reductions in antihypertensives, statins, or diabetes medicationsrepresent important positive outcomes

its effects can be felt as far away as the brain, heart, liver, kidneys, and more